JAK2V617F MPN小鼠模型:少数突变造血干细胞驱动疾病
大多数JAK2V617F敲入小鼠模型所有造血干细胞均携带突变,与人类早期MPN不符。本研究将JAK2V617F/WT敲入小鼠与PF4iCre转基因小鼠杂交,构建了突变仅存在于少数造血干细胞的小鼠模型。该模型早期出现血小板增多,10周龄时发展为类似真性红细胞增多症的表型,突变细胞频率随造血分化而增加,模拟了早期MPN的克隆扩增。
要点
- PF4iCre;JAK2V617F/WT小鼠早期出现血小板增多,10周龄出现PV样表型。
- Cre重组存在于所有造血区室,包括少量HSC,突变细胞频率随分化增加。
- 该模型模拟早期MPN中少数JAK2V617F HSC与多数JAK2WT HSC竞争的状态。
核心结论
- PF4iCre;JAK2V617F/WT小鼠模型模拟了早期MPN中少数突变HSC与多数野生型HSC竞争的克隆性造血状态。
研究设计与样本
- 将JAK2V617F/WT敲入小鼠与PF4iCre转基因小鼠杂交获得PF4iCre;JAK2V617F/WT小鼠。
- 使用mT/mG报告小鼠追踪Cre重组。
主要发现
- PF4iCre;JAK2V617F/WT小鼠因巨核细胞表达JAK2V617F而出现早期血小板增多。
- 该小鼠在10周龄时发展为类似真性红细胞增多症的表型。
- Cre重组存在于所有造血区室,包括少量HSC。
- 突变细胞频率随造血分化增加,模拟ET和PV患者的克隆扩增。
临床怎么用
- 该模型可作为研究克隆优势调控及向骨髓纤维化进展机制的工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The major weakness of most knock-in JAK2V617F mouse models is the presence of the JAK2 mutation in all rather than in a few hematopoietic stem cells (HSC), such as in human "early-stage" myeloproliferative neoplasms (MPN). Understanding the mechanisms of disease initiation is critical as underscored by the incidence of clonal hematopoiesis of indeterminate potential associated with JAK2V617F. Currently, such studies require competitive transplantation. Here, we report a mouse model obtained by crossing JAK2V617F/WT knock-in mice with PF4iCre transgenic mice. As expected, PF4iCre;JAK2V617F/WT mice developed an early thrombocytosis resulting from the expression of JAK2V617F in the megakaryocytes. However, these mice then developed a polycythemia vera-like phenotype at 10 weeks of age. Using mT/mG reporter mice, we demonstrated that Cre recombination was present in all hematopoietic compartments, including in a low number of HSC. The frequency of mutated cells increased along hematopoietic differentiation mimicking the clonal expansion observed in essential thrombocythemia and polycythemia vera patients. This model thus mimics the HSC compartment observed in early-stage MPN, with a small number of JAK2V617F HSC competing with a majority of JAK2WT HSC. PF4iCre;JAK2V617F/WT mice are a promising tool to investigate the mechanisms that regulate clonal dominance and progression to myelofibrosis.
引用
- Mansier O, Kilani B, Guitart AV, et al. Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells. Blood. 2019. PMID: 31697834. doi:10.1182/blood.2019001163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。